Cyclic Peptides in 2026: Why Researchers Are Exploring the Next Generation of Peptide Drugs
In the year 2026, cyclic peptides are attracting increasing attention in peptide drug discovery, but why?
It is because their ring-shaped structures can provide useful advantages over some linear peptides.
Unlike linear peptides, cyclic peptides contain a structural connection that closes the peptide chain into a ring. This constraint can reduce conformational flexibility and influence stability, molecular recognition, and target binding.
Research interest is also expanding beyond naturally occurring cyclic peptides. Modern screening, chemical synthesis, computational modeling, and molecular design are creating new opportunities for discovering synthetic cyclic peptide candidates.
A 2026 analysis published in the Journal of Medicinal Chemistry found continued growth in cyclic peptide publications and patents over the past two decades. The analysis also identified growing interest in oral administration and the relationship between cyclic peptide structure, chemical modification, biological targets, and delivery routes.
This makes cyclic peptides an important area to watch in peptide research in 2026.
However, cyclic peptides are not automatically better than linear peptides. Their properties depend heavily on sequence, ring size, chemical modifications, target, and intended route of administration.
What Are Cyclic Peptides?
Cyclic peptides are peptides with a cyclic structure, formed by connecting the ends of the amino acid chain with a chemical or biochemical bond.
Different amino acid residues and connections can form this bond, and several strategies are used to cyclize the peptide:
- Head-to-tail cyclization
- Side-chain-to-side-chain cyclization
- Disulfide-based cyclization
- Chemical crosslinking
- Modification of the peptide backbone
- Introduction of noncanonical amino acids.
Due to cyclization, a peptide acquires a unique three-dimensional structure, which reduces its conformational mobility. The ability to adopt specific conformations is often essential for the biological activity of cyclic peptides.
Cyclization changes the three-dimensional structure of a peptide. Instead of freely moving through many conformations, the molecule can become more structurally constrained.
This feature is important in cyclic peptide drug discovery because molecular shape can strongly affect how a peptide interacts with its biological target.
According to recent research, cyclic peptides are considered an emerging class of therapeutic molecules, occupying an intermediate position between conventional small molecules and biologics. They allow encoding extensive molecular recognition information in a discrete molecular framework, providing alternative approaches to studying and modulating a wide range of biological processes.
Why Are Cyclic Peptides Attracting More Research Interest?
There are several factors that contribute to increased research into cyclic peptides.
1. Conformational restriction
Cyclization can decrease the conformational freedom of a peptide
which can improve target engagement profiles (via increased conformational restriction for some molecular recognition features), as well as binding affinity and selectivity. However, similar to non-cyclic peptides, excessive structural restriction may hinder target engagement. Other considerations for cyclic peptides include their potential to resist enzymatic degradation and their ability to access “undruggable” targets.
2. Resistance to degradation
Certain cyclic peptides can display increased resistance to proteolytic degradation versus linear counterparts
Therefore, peptides can be valuable tools in understanding biology relevant to diseases, as well as potential therapeutics, particularly when cyclic motifs provide enhanced stability.
3. Access to challenging targets
Cyclic peptides occupy chemical space between small molecules and biologics, providing an interesting avenue of research into targets more challenging for small molecules to access, yet not as accessible for biologics. A promising area of research involves cyclic peptides that can penetrate cell membranes to target protein: protein interactions. This was demonstrated in a 2026 Nature Chemical Biology paper that showed that membrane-permeable cyclic peptides could be utilized to modulate protein: protein interactions, with further research ongoing into targeting protein: protein interactions within cells.
4. High-throughput screening capabilities
With the availability of phage display and mRNA display – and other high-throughput screening technologies – researchers can interrogate large peptide libraries to identify binders of a target of interest, including those that might not be found using conventional screening approaches.
A 2026 review highlights that de novo design of cyclic peptides is enabling cyclic peptide discovery, which has evolved from being reliant on natural product-inspired approaches.
5. Oral delivery
As highlighted in the 2026 Journal of Medicinal Chemistry review, oral delivery is a critical challenge for peptide therapeutics, and cyclic peptides – along with various modifications – are being explored as potential solutions.
Cyclic Peptides vs. Linear Peptides
Cyclic and linear peptides share the same basic building blocks, but their structures can produce different research properties.
| Feature | Linear Peptides | Cyclic Peptides |
| Structure | Open-chain structure | Closed-loop structure |
| Conformational flexibility | Often higher | Often more constrained |
| Proteolytic stability | Sequence-dependent | Can improve with cyclization |
| Target recognition | Depends on sequence and structure | Can benefit from conformational constraint |
| Synthesis | Often comparatively straightforward | Can require additional cyclization steps |
| Structural characterization | Established workflows | May require additional structural analysis |
| Oral delivery | Usually challenging | Potentially improved in some designs |
| Research applications | Broad | Increasingly studied for difficult targets |
The comparison does not mean cyclic peptides consistently outperform linear peptides.
For example, oral bioavailability depends on several molecular properties. An earlier analysis of peptide drugs found that oral administration is not determined simply by whether a peptide is cyclic or linear.
The sequence, molecular size, hydrogen bonding, lipophilicity, permeability, enzymatic stability, and formulation can all affect performance.
Cyclic Peptides and Oral Drug Delivery
One of the most important research questions concerns oral cyclic peptides.
Many peptide molecules have limited oral bioavailability because the gastrointestinal environment creates several barriers.
These include:
- Enzymatic degradation
- Poor membrane permeability
- Low gastrointestinal stability
- Large molecular size
- Unfavorable physicochemical properties
- Limited absorption across intestinal barriers
Cyclization can address some structural problems, but it does not automatically solve oral delivery.
Researchers therefore investigate cyclization alongside other approaches, including:
- Backbone modification
- N-methylation
- Noncanonical amino acids
- Permeation enhancement
- Lipophilicity adjustment
- Formulation technologies
- Controlled molecular flexibility
The goal is not simply to create a stable molecule. Researchers must create a molecule with an appropriate balance between stability, permeability, target binding, and biological activity.
Recent research continues to investigate how cyclic peptide structures can become sufficiently membrane-permeable for intracellular targets and oral administration.
Cyclic Peptides in Drug Discovery
Cyclic peptide drug discovery has changed significantly with improvements in library screening and molecular design.
Traditional peptide discovery often relied on natural products or known biological sequences. Modern platforms can generate and screen large numbers of synthetic peptide variants.
Major discovery approaches include:
- Phage display
- mRNA display
- Genetically encoded libraries
- Combinatorial chemistry
- Computational modeling
- Structure-based design
- Artificial intelligence-assisted design
These technologies allow researchers to investigate large chemical spaces and identify candidates with specific binding properties.
AI and computational approaches are also becoming relevant. A recent review describes how machine learning, deep learning, and physics-based simulations are being integrated into cyclic peptide discovery and optimization.
The combination of cyclic peptide synthesis, high-throughput screening, computational design, and biological testing could therefore expand the range of peptide structures available for research.
Why Are Cyclic Peptides Interesting for “Hard” Targets?
Proteins can have large binding sites with extended surfaces for molecular interaction.
Such binding sites are challenging for conventional small molecule drugs to target.
Cyclic peptides can offer a larger surface area for binding while also providing greater conformational restraint compared to unconstrained linear peptides.
This makes them particularly attractive for targeting challenging protein classes such as:
- Protein-protein interactions
- Intracellular signaling proteins
- Transcription factors
- Enzymes
- Receptors
- Disease-associated protein complexes
Researchers presented in 2026 a method for discovering chemically constrained cyclic peptides that inhibit transcription factor function, providing one example of how researchers are beginning to tackle more “difficult” intracellular targets through the use of functional screening of cyclic peptides.
However, it is important to note that a promising interaction in isolation does not necessarily mean that a particular peptide will make for a good drug.
Cyclic Peptide Research in Cancer and Other Disease Areas
Cyclic peptides are being investigated across several areas of biomedical research.
Potential research areas include:
Cancer research
Cyclic peptides can be investigated as targeting molecules, receptor ligands, enzyme inhibitors, and modulators of protein-protein interactions.
Their ability to recognize specific molecular targets makes them particularly interesting for targeted drug discovery.
Infectious disease research
Researchers are also exploring cyclic peptides as potential antimicrobial molecules and as tools for studying pathogen-associated targets.
Inflammatory and immune research
Cyclic peptide scaffolds can provide opportunities for designing selective ligands and protein interaction modulators.
Neurodegenerative disease research
Researchers have investigated cyclic peptides against aggregation-prone proteins and other molecular targets associated with neurodegenerative disorders.
These areas demonstrate the broad potential of cyclic peptide platforms, although individual candidates require independent experimental validation.
What Makes Cyclic Peptide Research Difficult?
The benefits that cyclic peptides provide are associated with considerable technical difficulties.
1. Cyclization can complicate synthesis
The formation of the desired ring structure requires specific chemical interactions.
Researchers must avoid intermolecular side reactions, incomplete cyclization, and the formation of undesirable structural isomers.
Recent studies continue to explore novel approaches to macrocyclization, as an effective and highly selective cyclization reaction remains a crucial synthetic challenge.
2. Purification can be challenging
Cyclic peptide synthesis can lead to the formation of a variety of closely related impurities.
These can arise from:
- Truncated sequences
- Linear precursors
- Non-specific cyclization
- Oxidation products
- Aggregation
- Diastereomeric or other structural isomers
Consequently, analytical separation becomes a critical requirement during research and development.
3. Structural characterization is essential
A high degree of purity alone cannot confirm the identity of a cyclic peptide.
Researchers may have to rely on analytical techniques such as:
- HPLC
- LC-MS
- High-resolution mass spectrometry
- NMR spectroscopy
- Other structural characterization methodologies
The choice of analytical approach will depend on the specific compound and research objective.
4. Scaling-up is challenging
A successful small-scale process may not work on a larger scale.
Kinetics, purification capacities, solvent use, yields, impurity profiles, and cyclization efficiency can all change when a synthesis moves from a laboratory to a larger-scale setting.
This creates a significant link between cyclic peptide research and peptide manufacturing.
Research Gaps in Cyclic Peptide Development
Despite rapid progress, several important research questions remain unresolved.
Oral bioavailability
The problem of how to predict which cyclic peptide structures will demonstrate oral bioavailability still needs addressing.
While structural stability is a concern, it is not a guarantee of intestinal absorption.
Cell permeability
There is a need for new approaches to enabling target engagement across cell membranes.
Many intracellular targets are not accessible to peptides, and it is challenging to design cyclic peptides that maintain their target affinity while demonstrating sufficient cell permeability.
Structure-property relationships
The relationships between structure and properties such as permeability, stability, solubility, and binding affinity are complex and multifaceted.
Developing new computational methods that better define the relationship between a cyclic peptide’s structure and increases the efficiency of experimental screening.
Manufacturing
Producing cyclic peptides on a commercial scale demands reliable synthesis, purification, characterization, and control.
Innovations in cyclization chemistries might help to some extent.
Safety and biological evaluation
Even if an interesting cyclic peptide is isolated, it is still necessary to perform a thorough biological evaluation before any conclusions about its potential as a therapeutic can be drawn.
Target engagement and selectivity, off-target effects, stability, toxicity, pharmacokinetics, and other factors must all be considered.
Why 2026 Could Be Important for Cyclic Peptide Research
Several developments make 2026 an interesting period for the field.
A 2026 Journal of Medicinal Chemistry analysis found sustained growth in cyclic peptide publications and patents. It also highlighted increasing attention toward oral administration and molecular design.
At the same time, research is moving beyond conventional peptide discovery.
Scientists are investigating:
- New macrocyclization chemistry
- Membrane-permeable cyclic peptides
- Functional peptide screening
- AI-assisted molecular design
- Intracellular targets
- Oral delivery strategies
- Automated peptide synthesis
- Improved analytical methods
For example, 2026 research has demonstrated new approaches for generating membrane-permeable cyclic peptides against protein-protein interactions.
Other recent work has explored new chemical methods for constructing macrocyclic peptides from native peptide sequences.
Together, these developments show that cyclic peptide research is expanding across chemistry, biology, computational science, and drug discovery.
Emerging Trends in Cyclic Peptide Research
AI-assisted cyclic peptide design
Computational models can help researchers evaluate large numbers of possible sequences and structures.
The field is increasingly combining artificial intelligence with molecular simulation and experimental screening.
Functional screening
Traditional screening often focuses on binding.
New approaches can instead select peptides based on their ability to produce a specific biological effect.
This could improve discovery against difficult intracellular targets.
Membrane-permeable cyclic peptides
Cell permeability remains one of the major challenges in intracellular peptide research.
Recent studies are specifically investigating cyclic peptide structures capable of crossing biological membranes.
Advanced macrocyclization chemistry
New chemical strategies may provide greater control over ring formation.
These methods could expand the structural diversity available for cyclic peptide research.
Oral cyclic peptide development
Oral delivery remains a major research goal.
Researchers are studying combinations of cyclization, chemical modification, formulation, and delivery technologies to overcome gastrointestinal barriers.
The Future of Cyclic Peptide Drug Discovery
The future of cyclic peptide research will likely depend on how effectively researchers solve several interconnected problems.
The first challenge is molecular design. Researchers need structures that balance target affinity, stability, permeability, and other physicochemical properties.
The second is discovery technology. Larger libraries and improved screening methods can increase the number of possible candidates researchers can investigate.
The third is delivery. Oral and intracellular delivery remain major areas of research.
The fourth is manufacturing. Successful candidates need scalable and reproducible synthesis and purification processes.
Finally, researchers need better models for predicting how cyclic peptide structure translates into biological behavior.
The field is therefore moving beyond a simple question of whether peptides can be cyclized. The more important question is how researchers can use cyclization as one design tool within a broader drug discovery strategy.
Conclusion
Cyclic peptides have become an important research area because their constrained structures can offer distinctive opportunities in peptide drug discovery.
Research in 2026 is exploring cyclic peptides for challenging molecular targets, oral delivery, intracellular activity, targeted drug discovery, and advanced peptide design.
Recent studies also show continued progress in screening technologies, computational design, membrane permeability, and macrocyclization chemistry.
At the same time, significant research gaps remain. Oral absorption, cell permeability, structural prediction, synthesis, purification, scale-up, and biological validation all require further investigation.
For researchers, the most useful approach is to view cyclic peptides as a versatile research platform rather than a universal replacement for linear peptides.
Frequently Asked Questions
1. What are cyclic peptides?
Cyclic peptides are peptides with a chemically or biologically closed structure. Their constrained shape can influence stability, binding, and other molecular properties.
2. Why are cyclic peptides important in drug discovery?
They can provide strong molecular recognition and may interact with targets that are difficult to address with some conventional small molecules.
3. Are cyclic peptides better than linear peptides?
Not necessarily. Their performance depends on sequence, structure, target, chemical modifications, and intended application.
4. Can cyclic peptides be taken orally?
Some cyclic peptides are being investigated for oral delivery. However, oral absorption depends on multiple molecular and formulation properties.
5. What is a macrocyclic peptide?
A macrocyclic peptide is a cyclic peptide with a relatively large ring structure. The terms are often used in overlapping contexts within medicinal chemistry.
6. What are the main challenges in cyclic peptide research?
Major challenges include synthesis, purification, structural characterization, cell permeability, oral bioavailability, scale-up, and biological validation.
7. Are cyclic peptides being studied for intracellular targets?
Yes. Recent research has investigated membrane-permeable cyclic peptides designed to modulate intracellular protein-protein interactions.
8. Is cyclic peptide research growing in 2026?
Recent bibliometric analysis published in 2026 reported sustained growth in cyclic peptide publications and patents, along with increasing interest in oral administration.
References
https://pubmed.ncbi.nlm.nih.gov/42480222
https://pubmed.ncbi.nlm.nih.gov/39388867
https://www.nature.com/articles/s41580-026-00971-3
https://pubmed.ncbi.nlm.nih.gov/40153992
https://pubmed.ncbi.nlm.nih.gov/27596610